Trials / Completed
CompletedNCT02105285
Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 193 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the efficacy and safety of OPC-1085EL ophthalmic solution in comparison with carteolol long-acting ophthalmic solution in subjects who are insufficiently responsive to carteolol long-acting ophthalmic solution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OPC-1085EL ophthalmic solution | |
| DRUG | Carteolol long-acting ophthalmic solution |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2015-01-01
- Completion
- 2015-01-01
- First posted
- 2014-04-07
- Last updated
- 2015-12-28
- Results posted
- 2015-11-17
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02105285. Inclusion in this directory is not an endorsement.